Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21732467 | 1.00 | ALOX15 (0.35) | ALOX15TSHRALDH1A1TDP1CYP3A4 | |
| SCHEMBL21732719 | 0.95 | ALOX15 (0.32) | ALOX15TSHRALDH1A1TDP1CYP3A4 | |
| SCHEMBL25670495 | 0.92 | ALOX15 (0.31) | ALOX15TSHRALDH1A1TDP1CYP3A4 | |
| SCHEMBL21732699 | 0.92 | ALOX15 (0.31) | ALOX15TSHRALDH1A1TDP1CYP3A4 | |
| SCHEMBL28699754 | 0.91 | ALDH1A1 (0.40) | ALOX15TSHRALDH1A1TDP1CYP3A4 | |
| SCHEMBL25670400 | 0.91 | ALOX15 (0.32) | ALOX15 | |
| SCHEMBL21732709 | 0.90 | ALOX15 (0.34) | ALOX15TSHRALDH1A1TDP1CYP3A4 | |
| SCHEMBL21732707 | 0.87 | ALOX15 (0.32) | ALOX15TSHRALDH1A1TDP1CYP3A4 | |
| SCHEMBL21732898 | 0.86 | TSHR (0.34) | TSHRALDH1A1 | |
| SCHEMBL21732712 | 0.86 | TSHR (0.34) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667866-B2 | Phosphorous containing compounds and uses thereof | AFTON CHEMICAL CORPORATION (US) | 2023-06-06 | — | — | US | disclosed |
| US-11667866-B2 | Phosphorous containing compounds and uses thereof | AFTON CHEMICAL CORPORATION (US) | 2023-06-06 | — | — | US | disclosed |
| US-20210355408-A1 | Phosphorous Containing Compounds and Uses Thereof | AFTON CHEMICAL CORP (US) | 2021-11-18 | — | — | US | disclosed |
| US-11066619-B2 | Phosphorous containing compounds and uses thereof | AFTON CHEMICAL CORPORATION (US) | 2021-07-20 | — | — | US | disclosed |
| US-20200056114-A1 | Phosphorous Containing Compounds and Uses Thereof | AFTON CHEMICAL CORP (US) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355408-A1 | Phosphorous Containing Compounds and Uses Thereof | SOST, PHOSPHO1, PSPH | ALOX15 735/4885TSHR 4882/4885ALDH1A1 4608/4885 |
| US-20200056114-A1 | Phosphorous Containing Compounds and Uses Thereof | SOST, PHOSPHO1, PSPH | ALOX15 735/4885TSHR 4882/4885ALDH1A1 4608/4885 |
| US-11667866-B2 | Phosphorous containing compounds and uses thereof | SOST, PHOSPHO1, PSPH | ALOX15 735/4885TSHR 4882/4885ALDH1A1 4608/4885 |
| US-11066619-B2 | Phosphorous containing compounds and uses thereof | SOST, PHOSPHO1, PSPH | ALOX15 735/4885TSHR 4882/4885ALDH1A1 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.